Viewing StudyNCT00350272

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 4:58 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00350272
Status: COMPLETED
Last Update Posted: 2023-08-30
First Post: 2006-07-06
Brief Title: ElvucitabineEfavirenzTenofovir Versus LamivudineEfavirenzTenofovir in Human Immunodeficiency Virus HIV-1 Infected Treatment-naive Participants
Sponsor: Alexion Pharmaceuticals Inc
Organization: Alexion Pharmaceuticals Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
HIV Infections
Keywords:
Name View
HIV-1 treatment naive View